[Postoperative bronchopleural complications in the combined treatment of lung cancer].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001983:Bronchial Fistula / Q000209:etiology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004307:Dose-Response Relationship, Radiation; D004653:Empyema / Q000209:etiology*; D005472:Fluorouracil / Q000627:therapeutic use; D006072:Gossypol / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D008875:Middle Aged; D010710:Phosphates / Q000627:therapeutic use; D010995:Pleural Diseases / Q000209:etiology*; D011013:Pneumonectomy / Q000009:adverse effects; D011182:Postoperative Care; D011183:Postoperative Complications / Q000209:etiology*; D011300:Preoperative Care; D011878:Radiotherapy / Q000009:adverse effects; D013852:Thiotepa / Q000627:therapeutic use; D013997:Time Factors
D000970:Antineoplastic Agents; D010710:Phosphates; D003520:Cyclophosphamide; D013852:Thiotepa; D006072:Gossypol; D005472:Fluorouracil
Posleoperatsionnye bronkhoplevral'nye oslozhneniia pri kombinirovannom lechenii raka legkogo